Eden Research (LON:EDEN) Shares Down 3.3% – Here’s Why

Posted by Matthew Jenks on Feb 22nd, 2025

Eden Research plc (LON:EDEN – Get Free Report) dropped 3.3% during trading on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares traded hands during trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The stock has a 50-day simple moving average of GBX 3.88 and a 200 day simple moving average of GBX 3.95. The stock has a market capitalization of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92.

Insider Buying and Selling

In other news, insider Lykele van der Broek bought 256,000 shares of the stock in a transaction on Thursday, February 6th. The shares were purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Also, insider Alexander John Abrey bought 540,540 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). 14.02% of the stock is currently owned by corporate insiders.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.